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Gene Array Expression Profiling in Acne Lesions
Reveals Marked Upregulation of Genes Involved
in Inflammation and Matrix Remodeling
Nishit R. Trivedi1,4, Kathryn L. Gilliland1,4, Wei Zhao2, Wenlei Liu2 and Diane M. Thiboutot1,3
The pathogenesis of acne has been linked to multiple factors such as increased sebum production,
inflammation, follicular hyperkeratinization, and the action of Propionibacterium acnes within the follicle. In
an attempt to understand the specific genes involved in inflammatory acne, we performed gene expression
profiling in acne patients. Skin biopsies were obtained from an inflammatory papule and from normal skin in six
patients with acne. Biopsies were also taken from normal skin of six subjects without acne. Gene array
expression profiling was conducted using Affymetrix HG-U133A 2.0 arrays comparing lesional to nonlesional
skin in acne patients and comparing nonlesional skin from acne patients to skin from normal subjects. Within
the acne patients, 211 genes are upregulated in lesional skin compared to nonlesional skin. A significant
proportion of these genes are involved in pathways that regulate inflammation and extracellular matrix
remodeling, and they include matrix metalloproteinases 1 and 3, IL-8, human b-defensin 4, and granzyme B.
These data indicate a prominent role of matrix metalloproteinases, inflammatory cytokines, and antimicrobial
peptides in acne lesions. These studies are the first describing the comprehensive changes in gene expression
in inflammatory acne lesions and are valuable in identifying potential therapeutic targets in inflammatory acne.
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INTRODUCTION
Acne is the most common skin condition affecting millions of
people worldwide. The pathogenesis of acne vulgaris is
complex and incompletely understood. Inflammation is a key
component of the pathogenesis of acne (Webster, 1995;
Harper and Thiboutot, 2003; Farrar and Ingham, 2004). An
immunological reaction to the Gram-positive microbe
Propionibacterium acnes may play a major role in the
initiation of the inflammatory reaction (De Young et al.,
1984; Jappe et al., 2002). Recently published studies also
implicate toll-like receptor 2 in inflammatory acne. P. acnes
triggers proinflammatory cytokine release from inflammatory
cells via activation of toll-like receptor 2, which in turn
initiates an intracellular signaling cascade resulting in the
transcription of genes such as IL-12 and IL-8 (Kim et al.,
2002). Furthermore, viable P. acnes and not heat-killed
organisms can stimulate the release of cytokines such as
IL-1b, GM-CSF, and IL-8 (Nagy et al., 2005; Schaller et al.,
2005).
Although the initiating events causing acne still remain a
mystery, there exists a debate as to whether hyperkeratiniza-
tion of the follicular duct precedes the influx of inflammatory
cells or vice versa. Recent studies support the latter
hypothesis by demonstrating that an increase in IL-1 activity
occurs before the hyperproliferation around uninvolved
follicles and this triggers the ‘‘keratinocyte activation cycle’’.
(Freedberg et al., 2001; Jeremy et al., 2003).
The skin expresses various antimicrobial peptides in
response to pathogens as part of cutaneous innate immunity
(Schroder, 2004; Braff et al., 2005; Selsted and Ouellette,
2005). These include members of the human b-defensin
family and granulysin-derived peptides (Harder et al., 2004;
Deng et al., 2005; McInturff et al., 2005). Human b-defensin
1 and 2 (DEFB1 and DEFB2) are expressed in the pilosebac-
eous unit and their expression is upregulated in acne lesions
(Chronnell et al., 2001). Recent studies also note that select
strains of P. acnes can activate DEFB2 through toll-like
receptors, further confirming the importance of these peptides
in inflammatory acne (Nagy et al., 2005).
Acne research during the last 25 years has significantly
increased our understanding about the etiological factors
giving rise to acne. With the advent of gene array expression
profiling however, new opportunities have arisen to
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re-examine the disease and potentially identify novel targets
in its treatment. The primary goal of this study is to identify
the specific genes expressed in inflammatory acne lesions
compared to normal skin from acne patients and to test the
hypothesis that differences in gene expression exist between
normal skin from acne patients and skin from subjects
without acne that may account for the predisposition to the
disease.
RESULTS
Expression of inflammatory mediators, antimicrobial peptides,
and matrix metalloproteinases is increased in acne lesions
compared to uninvolved skin
A distinct pattern of gene expression was seen from
inflammatory acne lesions compared to uninvolved skin
from the same patients. Analysis of the gene expression
profiles revealed that 211 genes were upregulated at the site
of the acne lesion, whereas 18 genes were downregulated
(false discovery rate¼0.01) (see Table S1 for a complete list).
A majority of the genes whose expression is increased in acne
lesions are involved with the inflammatory processes, and
these included a variety of chemokines, antimicrobial pepti-
des, apoptosis-inducing proteins, and interstitial collagenases
(Table 1 and Figure 1).
Genes with the greatest fold increases in expression in
acne lesions included the matrix metalloproteinases MMP-1
and MMP-3, which had 92- and 64-fold higher expression
patterns, respectively. Other genes that were significantly
upregulated included the proinflammatory cytokines IL-8 (52-
fold) and CXCL-2 (16-fold). Significant increases in the
expression of chemokine receptor 1, IL-7 receptor, IL-13
receptor, and IL-1 family members 5 and 9 were also noted.
These data highlight the prominent role of these cytokines in
inflammatory acne, which is in agreement with other studies
that demonstrate the role of IL-8 in inducing the recruitment
of chemotactic mediators at the site of acne lesions (Vowels
et al., 1995).
The expression of several antimicrobial peptides was also
significantly increased in acne lesions compared to normal
skin from the same patients. These include DEFB4 and
granulysin, which were upregulated by more than 33- and
two-fold, respectively. Genes involved in apoptosis and
immune pathways were also significantly upregulated in
acne lesions. These included granzyme B, which is respon-
sible for target cell lysis in cell-mediated immune responses,
and GPR65, which is involved with the differentiation of
T cells as well as their apoptosis. Granzyme B was
upregulated more than 10-fold in acne lesions when
compared to normal skin, whereas GPR65 was increased
by approximately 2.7-fold.
Although very few genes were downregulated in acne
lesions compared to normal skin, some important genes
regulating key pathways were identified (Table 2). The
frizzled related proteins, which function as part of the
‘‘Wnt’’ signaling pathway, were downregulated by approxi-
mately two-fold. Inhibition of ‘‘Wnt’’ signaling in the skin has
been shown to influence stem cell fate in favor of
development of sebocytes rather than hair (Merrill et al.,
2001). Also downregulated in acne lesions were three genes
of the secretoglobin family. Secretoglobin family 1D member
2 and secretoglobin family 2A member 1 are transcriptionally
regulated by steroids and bind to androgens and other
steroids. The function of secretoglobin family 2A member 2 is
unclear.
Gene expression profiles from biopsy samples of normal
skin from six subjects without acne were compared to profiles
obtained from normal skin (uninvolved sites) of six patients
with acne. No significant changes in gene expression patterns
were noted in this analysis (data not shown). A subset analysis
of target genes involved in inflammation (MMP-1, MMP-3,
IL-8, DEFB4, and granzyme B) was also performed in normal
skin from normal subjects and uninvolved skin from acne
patients. No statistically significant differences were identi-
fied between the two groups.
Cluster analysis
Hierarchical clustering of the entire set of genes (229) that
were significantly upregulated or downregulated from our
microarray data demonstrated that samples from inflamma-
tory acne lesions clustered into a separate group from the
normal skin from the same group of patients (Figure S1).
Using the NetAffix analysis center, we identified 41 genes
from a total of 211 genes upregulated in inflammatory acne to
be involved in inflammation. Figure 1 represents a cluster
diagram of the inflammatory genes and shows the unique
clustering pattern of the samples into two groups, one
corresponding to involved skin from acne lesion and another
corresponding to normal skin from the same group of six
patients. In the clustering diagram, each row represents a
gene and each column represents a sample. Clustering of
patient samples (columns) is indicated at the top of the
diagram. Genes with higher correlation coefficients among
the standardized gene expression values across samples are
clustered together by rows (for complete clustering tree, refer
to Figure S1). Therefore, genes in the same cluster should
have more similar expression patterns, whereas genes in
different clusters should have less similar expression patterns.
Quantitative PCR confirms gene array expression data of select
genes
We selected five genes of interest based on their fold changes
and involvement in inflammation from five acne subjects to
validate the microarray findings using qPCR. These genes
include, MMP-1, MMP-3, IL-8, b-defensin 4, and granzyme
B. qPCR results were normalized to the internal control gene,
TATA binding protein (TBP ). A robust increase in mRNA
expression was seen for all five genes tested, with the
magnitude of the fold change greater than that observed with
the microarray (Table 3).
Immunohistochemistry demonstrates tissue localization of
select proteins in inflammatory acne lesions and normal skin
To further confirm the differences in tissue expression and
distribution patterns of MMP-1 (interstitial collagenase), IL-8,
and DEFB4, we performed immunohistochemistry on inflam-
matory acne lesions, uninvolved skin from acne subjects, and
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Table 1. Genes significantly upregulated in acne lesions compared to normal skin
Probe set ID Accession Fold change Gene title Gene symbol
(A) Genes upregulated by more than 10-fold in acne lesions
204475_at NM_002421 92.166 matrix metalloproteinase 1 MMP1
205828_at NM_002422 64.020 matrix metalloproteinase 3 MMP3
202859_x_at NM_000584 52.521 interleukin 8 IL8
207356_at NM_004942 33.300 defensin, beta 4 DEFB4
203691_at NM_002638 19.354 protease inhibitor 3, skin-derived (SKALP) PI3
41469_at L10343 17.495 protease inhibitor 3, skin-derived (SKALP) PI3
204470_at NM_001511 16.152 chemokine (C-X-C motif) ligand 2 CXCL2
210873_x_at U03891 15.921 apolipoprotein B mRNA editing enzyme APOBEC3A
216841_s_at X15132 11.529 superoxide dismutase 2, mitochondrial SOD2
210164_at J03189 10.630 granzyme B GZMB
(B) Top 10 inflammatory genes upregulated in acne lesions
204475_at NM_002421 92.166 matrix metalloproteinase 1 MMP1
205828_at NM_002422 64.020 matrix metalloproteinase 3 MMP3
202859_x_at NM_000584 52.521 interleukin 8 IL8
207356_at NM_004942 33.300 defensin, beta 4 DEFB4
202833_s_at NM_000295 8.649 serine proteinase inhibitor, clade A SERPINA1
204563_at NM_000655 6.796 selectin L (lymphocyte adhesion molecule 1) SELL
205098_at AI421071 4.057 chemokine (C-C motif) receptor 1 CCR1
220322_at NM_019618 3.343 interleukin 1 family, member 9 IL1F9
201645_at NM_002160 3.022 tenascin C TNC
203645_s_at NM_004244 2.979 CD163 antigen CD163
(C) Top apoptosis-associated genes upregulated in acne lesions
210164_at J03189 10.630 granzyme B GZMB
214467_at NM_003608 2.772 G protein-coupled receptor 65 GPR65
204860_s_at AI817801 2.272 baculoviral IAP repeat-containing 1 BIRC1
201743_at NM_000591 2.211 CD14 antigen CD14
201739_at NM_005627 1.663 serum/glucocorticoid regulated kinase SGK
206545_at NM_006139 1.658 CD28 antigen (Tp44) CD28
219366_at NM_020371 1.627 apoptosis, caspase activation inhibitor AVEN
208315_x_at NM_003300 1.393 TNF receptor-associated factor 3 TRAF3
(D) Top genes involved in lipid and steroid metabolism upregulated in acne lesions
206561_s_at NM_020299 8.389 aldo-keto reductase family 1, member B10 AKR1B10
203649_s_at NM_000300 5.518 phospholipase A2, group IIA (platelets, synovial fluid) PLA2G2A
215125_s_at AV691323 2.804 UDP glycosyltransferase 1 family, polypeptide A10 UGT1A10
202430_s_at NM_021105 2.959 phospholipid scramblase 1 PLSCR1
208607_s_at NM_030754 2.659 serum amyloid A2 SAA2
202345_s_at NM_001444 2.268 fatty acid binding protein 5 (psoriasis-associated) FABP5
204446_s_at NM_000698 2.128 arachidonate 5-lipoxygenase ALOX5
203879_at U86453 1.461 phosphoinositide-3-kinase, catalytic, delta polypeptide PIK3CD
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on normal skin from subjects without acne. Increased
expression of all three proteins was noted in inflammatory
acne lesions when compared to normal skin from the acne
subjects. The expression of DEFB4 was greater in the
epidermis of inflammatory acne lesions when compared to
the epidermis in the uninvolved skin (Figure 2a and b).
Immunoreactivity with antibody to IL-8 was noted at the
follicular and perifollicular sites of the inflammation in the
acne lesion (Figure 2c). IL-8 immunoreactivity was relatively
absent in the normal skin (Figure 2d).
Whereas we found high levels of MMP-1 expression in the
epidermis and sebaceous glands in biopsy sections from the
inflammatory acne lesions (Figure 3b), we found variation
in MMP-1 expression in skin biopsies from the uninvolved
skin from the same acne patient (Figure 3c–e). In one of the
six biopsies of normal skin from acne patients, we obser-
ved perifollicular inflammation, suggestive of a clinically
unapparent acne lesion. MMP-1 immunoreactivity was
increased in the epidermis adjacent to perifollicular inflam-
mation (Figure 3c), whereas very little MMP-1 immunor-
eactivity was observed in those areas that had no
microscopically visible inflammation (Figure 3e). The higher
levels of MMP-1 expression at some sites of normal skin need
to be further examined to determine if changes in MMP-1
expression are among the earliest changes before the
development of comedones and inflammatory acne or if
an increase in MMP-1 persists during involution of an
inflammatory acne lesion.
Additional immunohistochemistry studies on skin biopsies
of psoriasis and folliculitis revealed that MMP-1 is also
expressed in the epidermis overlying inflammation and in
follicular epithelium in folliculitis lesions (Figure 4). These
data suggest that the rise in MMP-1 may be a part of a
generalized inflammatory reaction that is not specific to acne.
DISCUSSION
Acne is a chronic inflammatory disease, characterized by
increased sebum production, abnormal follicular differentia-
tion, and bacterial colonization. Although significant ad-
vances have been made in the last decade in identifying the
pathophysiological mechanisms involved in acne, there are
no published gene array studies analyzing the differential
pattern of gene expression in inflammatory acne lesions and
normal skin. Ours is the first study to provide such a
comprehensive comparison. In this regard, 211 genes were
significantly upregulated in inflammatory acne lesions, many
of which, as expected, are involved in inflammation. The
major genes whose expression was increased have been
implicated in acne. These include matrix metalloproteinases,
b-defensin 4, IL-8, and granulysin. In contrast, a much
smaller set of genes (18) were downregulated, three of which
are in the secretoglobin family. Despite evidence of small foci
of inflammation in clinically normal skin from acne patients,
no differences were noted between normal skin from acne
patients and that from patients without acne in the array
analysis. This is most likely due to the very small contribution
of a focus of inflammation to overall gene expression within a
5-mm biopsy of whole skin.
The recognition of microbial pathogens by immune cells
triggers host defense mechanisms to combat infection. These
defenses include antimicrobial peptides, inflammatory cyto-
kines, and proapoptotic enzymes. However, activation of
these same mechanisms also results in tissue injury and
scarring, a feature commonly observed in inflammatory acne.
The data generated in this study support many of the recent
findings regarding inflammatory mediators in acne, for
example, the extent to which P. acnes induces the expression
of the antimicrobial peptide, b-defensin 2 (now known as
DEFB4), and IL-8 (Nagy et al., 2005). As P. acnes is routinely
present in the skin of most individuals, and no correlation
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Figure 1. Hierarchical clustering of 41 inflammatory genes upregulated in
inflammatory acne identifies genes whose expression patterns segregate on
the basis of sample (normal skin vs acne lesion) and magnitude of change in
expression. Hierarchical clustering of genes involved in inflammation from
six patients with skin biopsies taken at the site of the acne lesion (AL) and at a
corresponding site of normal skin (NS) from the same patient. Each row
represents a gene labeled with gene name or accession number and each
column represents the patient sample. The color in each cell reflects the level
of expression of the corresponding gene in the corresponding sample, relative
to its mean level of expression in the entire set of biopsy samples. Expression
levels greater than the mean are shaded in red and those below the mean are
shaded in blue.
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between the number of bacteria and the severity and type of
acne has been found, differences in strain variations may
account for the differences in expression of b-defensin 4 or IL-
8 (Nagy et al., 2005). b-Defensin 4 demonstrates antimicro-
bial activity against both Gram-positive and Gram-negative
bacteria. Our data demonstrate that it is expressed in the
epidermis of inflammatory acne lesions, but not in normal
skin. These results are in agreement with other studies
demonstrating an increase in expression of b-defensin 1 and 2
Table 2. Genes significantly downregulated in acne lesions compared to normal skin
Probe set ID Accession Fold change Gene title Gene symbol
Complete list of genes that were downregulated in acne lesions
206799_at NM_006551 2.889 secretoglobin, family 1D, member 2 SCGB1D2
205979_at NM_002407 2.883 secretoglobin, family 2A, member 1 SCGB2A1
203824_at NM_004616 2.677 transmembrane 4 superfamily member 3 TM4SF3
212913_at BE674960 2.586 mutS homolog 5 (E. coli) MSH5
206378_at NM_002411 2.227 secretoglobin, family 2A, member 2 SCGB2A2
221406_s_at NM_025259 1.991 mutS homolog 5 (E. coli) MSH5
203697_at U91903 1.939 frizzled-related protein FRZB
219127_at NM_024320 1.879 hypothetical protein MGC11242 MGC11242
209842_at AI367319 1.766 SRY (sex determining region Y)-box 10 SOX10
201596_x_at NM_000224 1.656 keratin 18 KRT18
206606_at NM_000236 1.571 lipase, hepatic LIPC
205620_at NM_000504 1.547 coagulation factor X F10
219717_at NM_017741 1.522 hypothetical protein FLJ20280 FLJ20280
205388_at NM_003279 1.509 troponin C2, fast TNNC2
207265_s_at NM_016657 1.442 KDEL endoplasmic reticulum protein retention receptor 3 KDELR3
206747_at NM_014696 1.328 KIAA0514 KIAA0514
210006_at BC002571 1.325 DKFZP564O243 protein DKFZP564O243
31637_s_at X72631 1.310 nuclear receptor subfamily 1, group D, member 1 NR1D1
Table 3. Quantitative PCR confirms an increase in the
expression of select inflammatory genes
Fold change in
mRNA expression
(quantitative real-
time PCR) (mean7SD)
Fold change in
gene expression
(Gene Microarray data)
(mean)
MMP-1 +170718 +92
MMP-3 +165732 +64
IL-8 +181723 +52
DEFB4 +167720 +33
Granzyme B +1672 +11
The table represents the fold changes in mRNA expression for MMP-1,
MMP-3, IL-8, DEFB4, and granzyme B in inflammatory acne lesions and
biopsies of normal skin from the same group of patients. Statistical
analysis was performed by paired t-test: MMP-1, Po0.007; MMP-3,
Po0.05; DEFB4, Po0.02; *IL-8, Po0.03; granzyme B, Po0.008; n=5,
*n=4, one sample being an outlier was upregulated by more than 3,500-
fold in acne lesion. Comparative values of changes in gene expression are
also represented in the table.
MMP-1, matrix metalloproteinase 1; MMP-3, matrix metalloproteinase 1;
DEFB4, human b-defensin 4.
25 m
IL-8
IL-8
25 m
25 m
DEFB4
DEFB4
Normal skin
Acne lesion
a c
b d
Figure 2. Immunoreactivity to DEFB4 and IL-8 in skin biopsies confirms
array findings. Immunohistochemistry was performed on multiple sections of
acne skin and compared to those of clinically normal skin from the same
patient. (a, c) Expression of DEFB4 and IL-8 in biopsies from inflammatory
acne lesions. (b, d) Comparative staining for DEFB4 and IL-8 in biopsies from
clinically normal skin from the same patients.
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(DEFB4) in the epidermis of the inflammatory acne lesions
(Chronnell et al., 2001).
Granulysin is an antimicrobial peptide whose expression
is significantly increased in inflammatory acne lesions in our
study. It functions both as a cytotoxic agent against
pathogenic bacteria and as a chemoattractant that activates
monocytes to produce cytokines (Deng et al., 2005).
Antibiotics to combat P. acnes and other bacteria have been
commonly used in the treatment of acne and thus the
upregulation of these antimicrobial peptides produced by the
body can be helpful in killing the bacteria. Recent studies
have shown, however, that although some chemokines are
reduced as a consequence of the microbicidal effect of
granulysin peptides, the levels of IL-8 remain unchanged
(McInturff et al., 2005).
IL-8 is a major inflammatory mediator and a strong
chemotactic factor for neutrophis, basophils, and T cells
(Zachariae, 1993). Our study demonstrates that it is markedly
upregulated in inflammatory acne lesions. The activation of this
chemokine is regulated by a combination of three major
mechanisms, namely (a) the transcriptional activation by the
NF-kB and JUN protein kinase pathways, (b) stabilization of the
mRNA by the p38 mitogen-activated protein kinase pathway,
and (c) derepression of the gene promoter (Mukaida et al.,
1994; Harant et al., 1996; Hoffmann et al., 2002). As in several
inflammatory diseases, IL-8 has been implicated in mounting
an inflammatory response in acne lesions. Several studies have
focused on the role of P. acnes bacteria in inducing IL-8 and
discovered that this process may be mediated by the activation
of transcription factor NF-kB (Vowels et al., 1995; Cheng et al.,
2002). Thus, a detailed understanding of the pathways
governing IL-8 production may help us to identify newer
targets and better therapeutics for acne treatment.
The more recent studies by Kang et al. (2005) have focused
on identifying the various intracellular signaling cascades
associated with transcription factors involved in inflammation
and matrix degradation in acne lesions. The activation of NF-
kB pathway as evidenced by nuclear localization of p65 and
p50, and the subsequent regulation of inflammatory cytokines
such as tumor necrosis factor-a, IL-1b, and IL-8 have provided
clues that help our understanding of the molecular pathways
governing inflammation in acne (Kang et al., 2005). Our results
are in agreement with studies by Kang et al. in demonstrating
increased expression of matrix metalloproteinases, such as
MMP-1 and MMP-3, and cytokines, especially IL-8, in the
inflammatory acne lesions. In order to confirm if the
upregulation of MMP-1 was specific to acne, we performed
immunohistochemistry on sections of isolated folliculitis and
psoriasis and found high levels of expression of this metallo-
proteinase in the epidermis, suggesting a role of MMP-1 in
several inflammatory conditions.
Our study also demonstrates significant fold increases in
the expression of granzyme B in inflammatory acne lesions.
Granzyme B is an essential component of the apoptotic
pathway that is necessary for target cell lysis in cell-mediated
immune response (Heibein et al., 2000). It is commonly
found in granules produced by cytolytic T lymphocytes and
natural killer cells. Cytolytic T lymphocytes and natural killer
cells use perforin- and granzyme B-containing granules to
destroy cells infected with intracellular pathogens (Trapani
and Smyth, 2002). Although very little is known about the
role of granzyme B in the pathogenesis of acne, the strong
upregulation of granzyme B in acne lesions as observed in
our studies will help foster interest into a more in-depth study
of this protease in acne.
Skin from the site of acne lesion
MMP-1
MMP-1 MMP-1 MMP-1
IgG1 control
ba
c d e
Clinically normal skin from the same patient
25 m
Figure 3. Immunoreactivity to MMP-1 is increased in acne lesions and in
areas of microscopic inflammation in clinically normal skin. MMP-1
expressed in the epidermis and sebaceous glands in inflammatory acne shown
in (b) compared to IgG1 control shown in (a). Variable levels of MMP-1
staining can be seen in serial sections of clinically normal skin from the same
acne patient (c–e). A higher expression level of MMP-1 staining is seen in
the epidermis in sections close to microscopically visible perifollicular
inflammation (c) and progressively lower levels of MMP-1 staining is seen
in sites distal from it (d, e).
Folliculitis
Psoriasis
IgG-1
IgG-1
MMP-1
MMP-1
a b
c d
Figure 4. Increased levels of MMP-1 expression in other inflammatory skin
conditions. Increased levels of MMP-1 expression are seen in the epidermis
and perifollicular area of folliculitis (b) and in the epidermis of psoriasis (d),
compared to IgG1 controls (a, c).
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The upregulation of antimicrobial peptides is of interest,
further supporting their role in the endogenous inflammatory
response to bacterial pathogens and perhaps also providing a
rationale for their potential therapeutic use in acne. Critical
questions remain, however, as to the nature of the initiating
events in the development of acne lesions. It is likely that the
profiles of gene expression in any inflammatory process in the
skin are quite similar and that many of the changes observed
in inflammatory lesions are likely to be secondary to as yet
unidentified primary pathogenic events. The challenge lies
ahead in identifying these primary events in acne as well as in
other inflammatory diseases.
MATERIALS AND METHODS
Materials
The gene arrays ‘‘HG-U133A 2.0’’ were purchased from Affymetrix
(Santa Clara, CA). The MMP-1, MMP-3, IL-8, human b-defensin 4
(DEFB4), and granzyme B primers for real-time PCR were obtained
from Applied Biosystems (Foster City, CA). The primary antibodies
for immunohistochemistry of MMP-1 and IL-8 were purchased from
R&D systems (Minneapolis, MN) and DEFB4 from Abcam Inc.
(Cambridge, MA).
Patient selection and tissue biopsies
Twelve patients, including men and women, were enrolled in this
study. All patients signed a written informed consent. The study
was approved by the Institutional Review Board of the Pennsylvania
State University College of Medicine and was conducted according
to the Declaration of Helsinki Principles. The mean7SD ages
of the six acne patients and the six normal subjects were 2979 and
3976.8 years, respectively. The inclusion criteria for the acne lesion
group included (a) men and women aged 18–45 years with
inflammatory acne on their back, (b) subjects without other
skin disease in the biopsy area, (c) subjects who were willing to
have skin biopsies performed from their back, and (d) subjects who
have not been treated with isotretinoin for acne within the previous 6
months. The inclusion criteria for subjects without acne included (a)
men and women aged 18–45 years who were willing to have a skin
biopsy performed from their back and (b) subjects without other skin
disease in the biopsy areas. The exclusion criteria included subjects
who were taking oral medications that might influence gene
expression in the skin or applying topical medications in the target
areas on the back. A punch biopsy (5 mm) of the skin was performed
at two sites on the back of acne patients, one at the site of an
inflammatory acne papule and other from a region of clinically
normal skin. The acne lesions that were selected for biopsy were
new-onset inflammatory papules ranging in size from 3 to 4 mm that
were present on the mid-upper back. The diagnosis of acne was
substantiated by the presence of facial acne in addition to the
presence of comedones on the back of the subjects enrolled.
Biopsies of normal skin were taken at sites on the upper mid-back
that were as remote as possible from any visible acne lesions.
Normal subjects without acne were subjected to only one biopsy
taken from the mid-upper back.
Extraction of RNA, labeling, and hybridization to probe arrays
Total RNA was isolated from skin samples and DNase treated using
the RNeasy Fibrous Tissue Kit (Qiagen Inc., Valencia, CA). RNA was
ethanol precipitated and quantified using a spectrophotometer.
Approximately 2mg of total RNA from each sample was used to
generate double-stranded cDNA using a T7-oligo (dT) primer.
Biotinylated cRNA, produced through in vitro transcription, was
fragmented and hybridized to an Affymetrix human U133A 2.0
microarray. The arrays were processed on a GeneChip Fluidics
Station 450 and scanned on an Affymetrix GeneChip Scanner (Santa
Clara, CA).
Quantitative real-time PCR
Quantitative real-time PCR was performed to confirm changes in the
level of select genes from the array data. cDNA was generated from
1mg of total RNA, primed with oligo-dT, using the Superscript First-
Strand Synthesis System for reverse transcription-PCR (Invitrogen,
Carlsbad, CA). Applied Biosystems’ Assays-on-Demand Taqman
Universal PCR Master Mix and primer probe sets were used to run
real-time PCR on ABI’s 7900HT Fast Real-Time PCR System with
384-well plate block module (Applied Biosystems, Foster City, CA).
Samples corresponding to 80 ng of total RNA input were run in
triplicate for the reference gene TBP as well as six genes of interest:
MMP-1, MMP-3, DEFB4, IL-8, GZMB, and GATA6. No template and
no amplification controls were also run.
Immunohistochemistry
In order to verify changes in gene expression at the protein level, a
cohort of four additional subjects with acne were recruited to
undergo biopsies of an inflammatory acne papule and of uninvolved
skin from the back in a site remote from visible acne lesions. In
addition, skin samples from additional subjects without acne were
obtained to further assess the expression of the proteins of interest.
Immunohistochemistry was performed on paraffin-embedded sec-
tions following antigen retrieval. Sections were blocked with 1%
BSA and incubated with monoclonal antibody to MMP-1 (1:200) and
b-defensin 4 (1:100), and polyclonal antibody to IL-8 (1:50)
overnight at 41C. Slides were incubated with biotinylated secondary
antibodies against the respective primary antibodies at a dilution of
1:500 for 60 minutes at room temperature followed by 30 minutes
incubation with the ABC reagent (Vector Labs, Burlingame, CA). The
AEC kit (Vector Labs) was used as the chromogen, which stains as a
red color. The sections were counterstained with hematoxylin and
slides analyzed by microscopy. Negative controls consisted of
sections incubated with IgG1 in place of the primary antibody.
Archived paraffin-embedded specimens of inflammatory folliculitis
and psoriasis were also examined for the presence of MMP-1
immunoreactivity.
Cluster analysis
Out of the 211 genes that were upregulated in acne lesions, 41 were
identified as part of the inflammatory probe set generated from the
NetAffix Analysis Center from the Affymetrix website (http://
www.affymetrix.com/analysis/index.affx). Hierarchical clustering of
patient samples and genes involved in inflammation was performed
using the Computer software dChip version 1.3 (Li and Wong, 2003).
Patient samples included skin biopsies taken at the site of the acne
lesion and at a site of clinically normal skin from the same patient.
Normalized chip intensity data were imported into dChip. The gene
information file for Affymetrix human genome HG-U133A 2.0 array
was obtained from dChip’s website at www.dChip.org. Hierarchical
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clustering is used to compute a dendrogram that assembles all genes
or samples into a single tree.
Statistical analyses
Before testing significant changes in gene expression, the expression
signals were normalized by using the R-Affy package from
Bioconductor version 1.1 (Irizarry et al., 2003a, b) to remove
background noise and non-biological variations among arrays.
The background noise was removed from the PM probe intensities
using the ‘‘RMA’’ method (Irizarry et al., 2003a, b), which assumes a
global model for the distribution of probe intensities and models
the PM probe intensities as the sum of a normal noise component
and an exponential signal component. Normalization was
performed using the quantile normalization method (Bolstad
et al., 2003). Quantile normalization assumes that the expression
of the majority of genes on the arrays does not change in
different treatments and the distribution of probe intensities for each
array in the data set is the same. To remove outlier probes
and summarize probe intensities within one probe set into a
single expression value, the ‘‘Tukey Biweight’’ method was applied
to the background adjusted, normalized PM intensities. Expression
values were obtained based on PM intensities and not PM–MM
intensities, because PM and MM intensities were found to be
highly correlated, which suggested that MM intensities were
composed of background noise as well as probe-specific signals.
Significant gene expression alterations were identified using
the computer software Significance Analysis of Microarrays
(Tusher et al., 2001). Significance Analysis of Microarrays assigns a
score to each gene on the basis of gene expression change relative
to the standard deviation of repeated measurements and identifies
genes with statistically significant changes in expression
using a permutation procedure. Significance Analysis of Microarrays
controls the false positives resulting from multiple comparisons
through controlling the false discovery rate (Benjamini and
Hochberg, 1995). False discovery rate is defined as the proportion
of false positive genes among all genes that are considered
significant.
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SUPPLEMENTARY MATERIAL
Table S1. Comprehensive list of genes upregulated/downregulated in
inflammatory acne, compared to clinically normal skin from the same
patients.
Figure S1. Hierarchical clustering of 229 genes involved in inflammation from
six patients with skin biopsies taken at the site of the acne lesion (AL) and at a
corresponding site of normal skin (NS) from the same patient.
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